Showing results (21-30 of 62) with videos related to

Sort By:
Pageof 7
European Journal of Pharmacology|April 14, 1987
Effects of SAS 1310, a new calcium antagonist, on isolated myocardial and smooth muscle preparationsG Cargnelli, R Padrini, D Piovan, et al.
Clinical Pharmacokinetics|November 1, 1993
Pharmacokinetics and electrophysiological effects of intravenous ajmalineR Padrini, D Piovan, A Javarnaro, et al.
Nephron|January 25, 2000
Renal clearance of N(1)-methylnicotinamide: a sensitive marker of the severity of liver dysfunction in cirrhosisR Orlando, M Floreani, E Napoli, et al.
European Journal of Pharmacology|September 13, 1989
The influence of acidosis on the myocardial uptake and electrocardiographic effects of disopyramideS Bova, R Padrini, G Cargnelli, et al.
Clinical Pharmacology and Therapeutics|October 24, 2001
Severe phenytoin intoxication in a subject homozygous for CYP2C9*3R Brandolese, M G Scordo, E Spina, et al.
International Journal of Cardiology|February 22, 2001
Morphological algebraic models of the TU-wave patterns/in idiopathic long QT syndromeR Padrini, G Butrous, D Statters, et al.
The Journal of Pharmacology and Experimental Therapeutics|April 1, 1992
On the mechanism of vasodilating action of berberine: possible role of inositol lipid signaling systemS Bova, R Padrini, W F Goldman, et al.
Clinical Pharmacokinetics|August 1, 1991
Ajmaline test in a patient with chronic renal failure. A pharmacokinetic and pharmacodynamic studyR Padrini, L Compostella, D Piovan, et al.
Bollettino Della Societa Italiana Di Biologia Sperimentale|July 15, 1982
A report on the positive inotropic action of amrinoneG Cargnelli, R Padrini, D Piovan, et al.
Giornale Italiano Di Cardiologia|August 1, 1986
The myocardial levels of the antiarrhythmic drugs: clinical relevanceM Ferrari, R Padrini, D Piovan, et al.
Pageof 7